French Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2009

  1. Loss of the LAT Adaptor Converts Antigen-Responsive T Cells into Pathogenic Effectors that Function Independently of the T Cell Receptor

    Immunity, Vol. 31, Núm. 2, pp. 197-208

2007

  1. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: Insights into the mechanism of PLCγ2 activation

    Blood, Vol. 110, Núm. 7, pp. 2466-2474

2005

  1. Autistic effector T cells in mice with a point mutation in the LAT adaptor fail to respond to Listeria monocytogenes infection

    International Immunology, Vol. 17, Núm. 7, pp. 951-957

  2. The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse αβ- and γδ effector T cells

    Journal of Immunology, Vol. 175, Núm. 2, pp. 713-719

2003

  1. LAT regulates γδ T cell homeostasis and differentiation

    Nature Immunology, Vol. 4, Núm. 10, pp. 999-1008

  2. Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of αiib/β3

    Journal of Thrombosis and Haemostasis, Vol. 1, Núm. 2, pp. 320-329

2002

  1. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor

    Science, Vol. 296, Núm. 5575, pp. 2036-2040

  2. Non-T cell activation linker (NTAL): A transmembrane adaptor protein involved in immunoreceptor signaling

    Journal of Experimental Medicine, Vol. 196, Núm. 12, pp. 1617-1626

1999

  1. Functional expression of CD43 on human natural killer cells

    Journal of Leukocyte Biology, Vol. 66, Núm. 6, pp. 923-929